Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Sunil Sudunagunta v. Nantkwest, Inc. et al
Case Number:
2:16-cv-01947
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Baker & Hostetler
- Bragar Eagel
- Freshfields
- Glancy Prongay
- Munger Tolles
- Pomerantz LLP
- Robbins Geller
- Schall Law
- Stull Stull
- Wilson Sonsini
- Withersworldwide
Companies
Sectors & Industries:
-
November 13, 2018
Investors Reach $12M Deal In Biotech Stock-Drop Case
A shareholder class claiming biotech company NantKwest hid millions of dollars in executive compensation expenses from investors prior to its 2015 initial public offering has reached a $12 million proposed settlement with the firm, according to a filing in California federal court.
-
August 13, 2018
Investors Secure Class Cert. In Biotech Stock-Drop Case
A California federal judge on Monday certified a shareholder class alleging that biotech company NantKwest didn't tell investors the company had incurred over $114 million in executive compensation expenses for its chief executive officer prior to its $225 million initial public offering in 2015.